Pneumologie 2023; 77(S 01): S17
DOI: 10.1055/s-0043-1760904
DOI: 10.1055/s-0043-1760904
Abstracts
Osimertinib as adjuvant therapy in patients with resected EGFRm stage IB-IIIA NSCLC: updated results from ADAURA
C Grohé
1
Evangelische Lungenklinik Berlin Buch
,
M Tsuboi
2
National Cancer Center Hospital East
,
Y Wu
3
Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences
,
T John
4
Austin Health
,
M Majem
5
Hospital de la Santa Creu I Sant Pau
,
J Wang
6
Chinese Academy of Medical Sciences
,
T Kato
7
Kanagawa Cancer Center, Asahi Ward
,
J Goldman
8
David Geffen School of Medicine at University of California Los Angeles
,
S Kim
9
Asan Medical Center
,
C Yu
10
National Taiwan University Hospital and National Taiwan University College of Medicine
,
H Vu
11
Cho Ray Hospital
,
G Mukhametshina
12
Republican Clinical Oncology Center
,
C Akewanlop
13
Siriraj Hospital
,
F de Marinis
14
European Institute of Oncology (Ieo), Irccs
,
F Shepherd
15
University Health Network, Princess Margaret Cancer Centre
,
D Urban
16
Sheba Medical Center, Tel Hashomer, Israel and Sackler Faculty of Medicine
,
M Stachowiak
17
Astrazeneca
,
A Balanos
17
Astrazeneca
,
X Huang
17
Astrazeneca
,
R Herbst
18
Yale School of Medicine and Yale Cancer Center
,
J Kern
19
Kwm Missio Clinic
› Institutsangaben
